Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) Revenue
Revenue
EGP 962.94M
Fiscal year 2019
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2019 | 962.94M | 11.59% |
| 2018 | 862.95M | 25.03% |
| 2017 | 690.18M | 33.6% |
| 2016 | 516.6M | 14.55% |
| 2015 | 450.98M | 11.52% |
| 2014 | 404.38M | 7.89% |
| 2013 | 374.81M | 9.38% |
| 2012 | 342.65M | 12.13% |
| 2011 | 305.58M | 5.81% |
| 2010 | 288.79M | 7.51% |
| 2009 | 268.61M | 3.33% |
| 2008 | 259.95M | 6.48% |
| 2007 | 244.13M | 5.2% |
| 2006 | 232.06M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.